Company Filing History:
Years Active: 2022
Title: Raj Raheja: Innovator in Antiproliferative Compounds
Introduction
Raj Raheja is a notable inventor based in the United States, recognized for his contributions to the field of cancer treatment. His work focuses on developing innovative compounds aimed at treating, preventing, or managing various forms of cancer, including leukemia.
Latest Patents
Raj Raheja holds a patent for "Antiproliferative Compounds And Methods Of Use Thereof." This patent discloses compounds of formula (I) that are designed for the treatment of cancer. The methods outlined in the patent include administering these compounds in combination with a second agent to enhance their effectiveness.
Career Highlights
Throughout his career, Raj Raheja has made significant strides in pharmaceutical research. His work has contributed to the development of pharmaceutical compositions and single unit dosage forms that incorporate his innovative compounds.
Collaborations
Raj has collaborated with notable colleagues, including Joshua Hansen and Matthew Daniel Correa, to advance his research and patent applications. Their combined expertise has played a crucial role in the development of his patented compounds.
Conclusion
Raj Raheja's innovative work in antiproliferative compounds showcases his commitment to advancing cancer treatment. His contributions are vital in the ongoing fight against cancer, and his research continues to inspire future developments in the field.